EUVIMEDEUVIMED entdecken
Crossref

Multimodal Antiatherosclerotic Effects of Clinical-Grade Mesenchymal Stem Cell–Derived Extracellular Vesicles

Jooho Kim iD, Doil Park iD, Jaein Yoo iD, Ji Eun Kim iD, Eun Hee Kim iD, Oh Young Bang iD

Stroke · 2026

DOI: 10.1161/strokeaha.125.052894 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stroke, 2026. Verfasst von Jooho Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences and Technology, Samsung Advanced Institute for Health Science & Technology (SAIHST), Sungkyunkwan University, Seoul, So…. Hauptthemen laut MEDLINE: Atherosclerosis, Extracellular Vesicles, Mesenchymal Stem Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Atherosclerosis remains a leading cause of cardiovascular diseases. Despite current lipid-lowering therapies, residual risk persists due to inflammation and elevated Lp(a) (lipoprotein[a]) levels. Mesenchymal stem cell–derived extracellular vesicles show promise as a novel therapeutic modality. This hypothesis-testing (new) study investigated the antiatherosclerotic effect and systemic lipid-modulating potential of the clinical-grade mesenchymal stem cell–derived extracellular vesicle product SNE-101, which is currently approved for acute ischemic stroke trials. METHODS: ApoE−/− (apolipoprotein E–deficient) mice (male, 6–8 weeks old; n=6 per group) were placed on a high-fat diet, and SNE-101 (6×10⁸ particles) was administered intravenously via the tail vein once weekly for 4 weeks. The primary exposure variable was SNE-101 treatment, and the primary outcome variable was aortic plaque burden, quantified as the percentage of Oil Red O–stained area. In vitro foam cell assays were performed to assess cholesterol efflux. RESULTS: In vitro, SNE-101 significantly reduced lipid accumulation and enhanced cholesterol efflux via upregulation of the PPARγ (peroxisome proliferator-activated receptor gamma)/LXRα (liver X receptor alpha)/ABCA1 (ATP-binding cassette transporter A1)/ABCgG1 (ATP-binding cassette transporter G1) axis ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisExtracellular VesiclesMesenchymal Stem CellsAnimalsMaleMiceApolipoproteins ECholesterolMice, Knockout, ApoEMice, KnockoutFoam CellsDiet, High-Fat

Stichwörter der Autor:innen

atherosclerosischolesterolextracellular vesiclesinflammationstem cells

Substanzen

Apolipoproteins ECholesterol

Autor:innen und Institutionen

  • Department of Health Sciences and Technology, Samsung Advanced Institute for Health Science & Technology (SAIHST), Sungkyunkwan University, Seoul, South Korea (J.K., D.P., J.Y., O.Y.B.).
  • S&E bio, Inc, Seoul, South Korea (J.E.K., E.H.K., O.Y.B.).
  • Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (O.Y.B.).

ORCID-Profile: Jooho Kim, Doil Park, Jaein Yoo, Ji Eun Kim, Eun Hee Kim, Oh Young Bang

Zitieren

APA

Kim, J., Park, D., Yoo, J., Kim, J. E., Kim, E. H., & Bang, O. Y. (2026). Multimodal Antiatherosclerotic Effects of Clinical-Grade Mesenchymal Stem Cell–Derived Extracellular Vesicles. Stroke. https://doi.org/10.1161/strokeaha.125.052894

Vancouver

Kim J, Park D, Yoo J, Kim JE, Kim EH, Bang OY. Multimodal Antiatherosclerotic Effects of Clinical-Grade Mesenchymal Stem Cell–Derived Extracellular Vesicles. Stroke. 2026. doi:10.1161/strokeaha.125.052894

BibTeX
@article{Kim2026,
  author = {Kim, Jooho and Park, Doil and Yoo, Jaein and Kim, Ji Eun and Kim, Eun Hee and Bang, Oh Young},
  title = {Multimodal Antiatherosclerotic Effects of Clinical-Grade Mesenchymal Stem Cell–Derived Extracellular Vesicles},
  journal = {Stroke},
  year = {2026},
  doi = {10.1161/strokeaha.125.052894}
}
Kostenlos starten →